What we're about
Advancing prediction, prevention, and precision therapy for patients with rheumatic diseasesWho we are
Over 200 researchers spanning the basic, clinical, and analytical sciencesHow we help
World-class core facilities and investigator support to drive groundbreaking research and launch distinctive careersWhy we care
Patients with rheumatic diseases need better tests and personalized treatments so they can live healthier, longer lives
Recent Publications
- Reply October 17, 2024
- Variants in the <em>DDX6-CXCR5</em> autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland July 29, 2024
- Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment Response July 4, 2024
- Neutrophils isolated from systemic lupus erythematosus patients exhibit a distinct functional phenotype March 25, 2024
- Massively parallel reporter assay confirms regulatory potential of hQTLs and reveals important variants in lupus and other autoimmune diseases February 23, 2024
- Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial February 1, 2024
- Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis January 23, 2024